Kinoshita H, Ohishi N, Kato M, Tokura S, Okazaki A
Drug Metabolism Laboratory, Chugai Pharmaceutical Co., Ltd., Tokyo, Japan.
Arzneimittelforschung. 1991 Sep;41(9):1004-7.
Comparative pharmacokinetic and distribution studies of human recombinant erythropoietin (rh-EPO, Epoch, CAS 11096-26-7) and human urinary erythropoietin (u-EPO) were performed in rats. The pharmacokinetic parameters following intravenous administration of rh-EPO were similar to those of u-EPO. With respect to the concentrations of radioactivity in the liver reflecting uptakes of asialoglycoprotein, there were no differences in the concentrations between 125I-rh-EPO and 125I-u-EPO. The concentrations of radioactivity in the target organs, i.e., bone marrow and spleen in rats given 125I-rh-EPO were very similar to those of rats given 125I-u-EPO. These facts are most likely to reflect the similarity in pharmacological action.